Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.
Press releases published on August 11, 2025
Anteris Announces Results for the Second Quarter of 2025
GlobeNewswire
·
August 11, 2025
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercialising cutting-edge …
TPI Composites, Inc. Initiates Voluntary Chapter 11 Proceedings to Facilitate Restructuring to Position Company for Long-Term Success
GlobeNewswire
·
August 11, 2025
Reaches Agreement with Senior Secured Lenders for Use of Cash Collateral and Up to $82.5 Million in Debtor-in-Possession Financing, Subject to Final Documentation and Court Approval DIP Financing to Facilitate Path to Comprehensive Restructuring and …
SPX Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
August 11, 2025
CHARLOTTE, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- SPX Technologies, Inc. (NYSE:SPXC) (“SPX”) announced today that it intends to offer and sell $500 million of shares of its common stock in an underwritten public offering. In addition, SPX intends to grant …
Constellation Brands to Present at the 2025 Barclays Global Consumer Staples Conference on September 2, 2025
GlobeNewswire
·
August 11, 2025
ROCHESTER, N.Y., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that Bill Newlands, President and Chief Executive Officer, and Garth Hankinson, Executive Vice President and …
Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900
GlobeNewswire
·
August 11, 2025
The Phase 1b program is designed to evaluate the clinical activity of NXP900 as a single agent in patients with advanced solid tumors whose cancers harbor specific genetic alterations, and in combination with EGFR and ALK inhibitors in patients with NSCLC …
Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
GlobeNewswire
·
August 11, 2025
MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its …
Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
August 11, 2025
HUNTSVILLE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate, SER-252, for advanced Parkinson's disease, enabled by its proprietary POZ …
RGC Resources, Inc. Reports Third Quarter Earnings
GlobeNewswire
·
August 11, 2025
ROANOKE, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (Nasdaq: RGCO) announced consolidated earnings of $538,412, or $0.05 per share, for the third quarter ended June 30, 2025, compared to $156,692, or $0.02 per share, for the fiscal quarter …
J & J SNACK FOODS CORP. ANNOUNCES INCREASE IN ITS QUARTERLY CASH DIVIDEND
GlobeNewswire
·
August 11, 2025
MOUNT LAUREL, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- J …
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
GlobeNewswire
·
August 11, 2025
Business combination transaction with Helix Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Cormorant Asset Management, completed on August 11, 2025 Closed concurrent $261 million private investment in public equity …
Avista Announces New Executive Appointments
GlobeNewswire
·
August 11, 2025
SPOKANE, Wash., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Avista (NYSE: AVA) today announced a few changes to its leadership team, effective Oct. 1, 2025, as part of a planned succession strategy designed to enhance the company’s operational capabilities, …
Biofrontera Inc. Appoints George Jones as Chief Commercial Officer
GlobeNewswire
·
August 11, 2025
Woburn, MA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), today announced the appointment of George Jones as …
Proficient Auto Logistics Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
JACKSONVILLE, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the “Company” or “Proficient”) today reported its financial results for the three months ended June 30, 2025, and comparative summary financial information …
Artisan Partners Asset Management Inc. Reports July 2025 Assets Under Management
GlobeNewswire
·
August 11, 2025
MILWAUKEE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of July 31, 2025 totaled $175.0 billion. Artisan Funds and Artisan Global Funds …
Microchip Technology to Present at the KeyBanc Technology Leadership Forum
GlobeNewswire
·
August 11, 2025
CHANDLER, Ariz., Aug. 11, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Mizuho 2025 Technology …
Longeveron Announces Closing Of Up To $17.5 Million Public Offering
GlobeNewswire
·
August 11, 2025
MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related …
Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire
·
August 11, 2025
FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first new drug for fibromyalgia in more than 16 years In June 2025, the Company was added to the Russell 3000® and Russell 2000® Indexes …
AMD to Host Financial Analyst Day on November 11, 2025
GlobeNewswire
·
August 11, 2025
SANTA CLARA, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced it will host its 2025 Financial Analyst Day on Tuesday, Nov. 11, 2025, in New York City. The event will feature presentations from AMD’s executive leadership team, …
3D Systems Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 11, 2025
ROCK HILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2025. Revenue of $95 million led by double-digit growth in Medical Technology and Aerospace …
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 11, 2025
Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in China Granted orphan drug designation from the European Medicines Agency (EMA) for amezalpat for the treatment of patients …